Articles published by Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics Announces Changes to its Board of Directors
September 04, 2024
Via GlobeNewswire
Tickers
BOLT
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 13, 2024
Via GlobeNewswire
Tickers
BOLT
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
November 09, 2023
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference
November 07, 2023
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancer’s 2023 Annual Meeting
October 18, 2023
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics Receives Orphan Drug Designation for BDC-1001 for Treatment of Gastric Cancers
September 28, 2023
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics to Participate in September Investor Conferences
September 05, 2023
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
August 07, 2023
Via GlobeNewswire
Tickers
BOLT
Via GlobeNewswire
Tickers
BOLT
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics to Present at February Investor Conferences
February 01, 2023
Via GlobeNewswire
Tickers
BOLT
Bolt Biotherapeutics Appoints Laura Berner to Board of Directors
December 14, 2022
Via GlobeNewswire
Tickers
BOLT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.